Clinical Trial Update: Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing cetuximab and trastuzumab in metastatic pancreatic cancer after gemcitabine failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED